Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Influenza
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Prevention
Participation Requirements
- Age
- Younger than 635 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04363359
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Shilei Wang, PhD Shanghai Institute Of Biological Products
Get Well Soon